Greenville Health System

Greenville, South Carolina 61103

0 studies enrolling now · 76 studies all time

What they study most

AV Block, Acute Coronary Syndrome, Advanced Breast Cancer, Advanced Solid Tumor, Advanced Solid Tumors, Advanced, Androgen Receptor Positive Triple Negative Breast Cancer, Anemia, Aneurysm, Aneurysms, Arterio-Venous Fistula, Atherosclerosis, Breast Cancer

Studies at this site

• A Study to Look at Performance of MICRUSFRAME and GALAXY Coils for the Treatment of Intracranial Aneurysms — Completed
• VasQ External Support for Arteriovenous Fistula — Completed
• Study of Ibrutinib and Rituximab in Treatment Naïve Follicular Lymphoma — Completed
• Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: The STEMI-DTU Trial — Running, not enrolling
• XIENCE Skypoint Large Vessel Post Approval Study — Running, not enrolling
• An Integrated Intervention Involving Recovery Coaching and Cognitive Behavioral Therapy for Opioid Use Disorder — Completed
• A Trial to Find and Investigate a Safe Dose of a New Substance (BI 754091) for Patients With Solid Tumours — Completed
• A Study of Subcutaneous Nivolumab Monotherapy With or Without Recombinant Human Hyaluronidase PH20 (rHuPH20) — Completed
• Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML) — Completed
• Trilaciclib (G1T28) in Patients With Previously Treated Extensive Stage SCLC Receiving Topotecan Chemotherapy — Completed
• Efficacy and Safety Study of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast Cancer — Completed
• GRAVITAS-301: A Study of Itacitinib or Placebo in Combination With Corticosteroids for Treatment of Acute Graft-Versus-Host Disease — Completed
• Safety Study of Enoblituzumab (MGA271) in Combination With Pembrolizumab or MGA012 in Refractory Cancer — Completed
• Hemodynamic-GUIDEd Management of Heart Failure — Completed
• The DETOUR 2 Clinical Trial — Completed
• FUnctional diagnoSIs of corONary Stenosis (FUSION) — Completed
• Intensive Models of HCV Care for Injection Drug Users — Completed
• Abbott Next Generation Drug Eluting Stent 48mm Study — Completed
• Safety and Efficacy Study of Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple Negative Breast Cancer — Completed
• FAVOR Opioid Recovery Coaching Evaluation — Completed
• Pre-operative Alcohol Skin Solutions in Fractured Extremities — Completed
• Palbociclib in Real World Practice — Completed
• LCI-HEM-SCD-ST3P-UP-001: The Sickle Cell Trevor Thompson Transition Project (ST3P-UP Study) — Completed
• ILUMIEN IV: OPTIMAL Percutaneous Coronary Intervention (PCI) — Completed
• Myocardial Ischemia and Transfusion — Completed
• A First-in-Humans Dose Finding Study for an Aryl Hydrocarbon Receptor Inhibitor (AhRi) in Patients With Advanced Cancer — Completed
• The Safety and Tolerability of GT0918 in Subjects With mHSPC and mCRPC — Completed
• Use of a Self-Directed Exercise Program (SDEP) Following Selected Lower Extremity Fractures — Completed
• Lisocabtagene Maraleucel (JCAR017) as Second-Line Therapy (TRANSCEND-PILOT-017006) — Completed
• A RCT of CenteringPregnancy on Birth Outcomes and Maternal Inflammation — Completed
• Evaluation of VISITAG SURPOINT™ Module With External Processing Unit (EPU) — Completed
• Stellarex DCB Versus Standard Balloon Angioplasty for Treatment of Below-The-Knee (BTK) Arteries — Paused
• Pre-operative Aqueous Antiseptic Skin Solutions in Open Fractures — Completed
• Study to Assess the Effect of Omecamtiv Mecarbil on Exercise Capacity in Subjects With Heart Failure — Completed
• Autologous Muscle Derived Cells for Female Urinary Sphincter Repair — Completed
• A Safety Trial of Nivolumab in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Progressed During or After Receiving At Least One Prior Chemotherapy Regimen — Completed
• Study of Nanoliposomal Irinotecan (Nal-IRI)-Containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma — Completed
• Operative and Non-operative Treatment of Traumatic Arthrotomies — Completed
• An Open Label Investigational Immuno-therapy Trial of Nivolumab in Cancers That Are Advanced or Have Spread — Completed
• The Role of the Robotic Platform in Inguinal Hernia Repair Surgery — Completed
• Amniotic Membrane Allograft Application in the Management of Venous Leg Ulcerations — Stopped early
• Tailored Antiplatelet Therapy Following PCI — Completed
• A Study of Elotuzumab in Combination With Pomalidomide and Low Dose Dexamethasone and Elotuzumab in Combination With Nivolumab in Patients With Multiple Myeloma Relapsed or Refractory to Prior Treatment With Lenalidomide. — Completed
• Phase 1b Safety and Efficacy Study of TRU-016 — Stopped early
• A Study of Nivolumab in Advanced Non-Small Cell Lung Cancer (NSCLC) — Completed
• A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor — Completed
• Optimal Treatment for Women With a Persisting Pregnancy of Unknown Location — Completed
• Phase 1b Study of Weekly Carfilzomib in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma — Completed
• HBP Device EGM Data Collection — Completed
• Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Etoposide and Carboplatin in Extensive Stage Small Cell Lung Cancer (SCLC) — Completed